Adapthealth Corp
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. The company offers sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and … Read more
Market Cap & Net Worth: Adapthealth Corp (AHCO)
Adapthealth Corp (NASDAQ:AHCO) has a market capitalization of $1.42 Billion ($1.42 Billion) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #7688 globally and #4023 in its home market, demonstrating a 7.94% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Adapthealth Corp's stock price $10.47 by its total outstanding shares 135424334 (135.42 Million).
Adapthealth Corp Market Cap History: 2018 to 2026
Adapthealth Corp's market capitalization history from 2018 to 2026. Data shows growth from $1.33 Billion to $1.42 Billion (0.98% CAGR).
Index Memberships
Adapthealth Corp is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.20 Trillion | 0.04% | #208 of 976 |
|
NASDAQ Composite
IXIC
|
$32.97 Trillion | 0.00% | #845 of 3165 |
|
S&P Small-Cap 600 Index
SML
|
$1.35 Trillion | 0.08% | #437 of 602 |
Weight: Adapthealth Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Adapthealth Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Adapthealth Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.40x
Adapthealth Corp's market cap is 0.40 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
14.26x
Adapthealth Corp's market cap is 14.26 times its annual earnings
1.94x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $1.33 Billion | $345.28 Million | $2.09 Million | 3.86x | 638.14x |
| 2019 | $1.49 Billion | $529.64 Million | -$21.34 Million | 2.81x | N/A |
| 2020 | $5.09 Billion | $1.06 Billion | -$161.63 Million | 4.82x | N/A |
| 2021 | $3.31 Billion | $2.45 Billion | $156.18 Million | 1.35x | 21.21x |
| 2022 | $2.60 Billion | $2.97 Billion | $69.32 Million | 0.88x | 37.55x |
| 2023 | $987.24 Million | $3.20 Billion | -$678.89 Million | 0.31x | N/A |
| 2024 | $1.29 Billion | $3.26 Billion | $90.42 Million | 0.40x | 14.26x |
Competitor Companies of AHCO by Market Capitalization
Companies near Adapthealth Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Adapthealth Corp by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
Adapthealth Corp Historical Marketcap From 2018 to 2026
Between 2018 and today, Adapthealth Corp's market cap moved from $1.33 Billion to $ 1.42 Billion, with a yearly change of 0.98%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $1.42 Billion | +5.12% |
| 2025 | $1.35 Billion | +4.62% |
| 2024 | $1.29 Billion | +30.59% |
| 2023 | $987.24 Million | -62.07% |
| 2022 | $2.60 Billion | -21.42% |
| 2021 | $3.31 Billion | -34.88% |
| 2020 | $5.09 Billion | +242.08% |
| 2019 | $1.49 Billion | +11.70% |
| 2018 | $1.33 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Adapthealth Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.42 Billion USD |
| MoneyControl | $1.42 Billion USD |
| MarketWatch | $1.42 Billion USD |
| marketcap.company | $1.42 Billion USD |
| Reuters | $1.42 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.